These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31315305)

  • 1. Severe Type of Minocycline-Induced Hyperpigmentation Mimicking Peripheral Arterial Occlusive Disease in a Bullous Pemphigoid Patient.
    Wu MY; Hou YT; Yiang GT; Tsai AP; Lin CH
    Antibiotics (Basel); 2019 Jul; 8(3):. PubMed ID: 31315305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline-induced hyperpigmentation in patients with pemphigus and pemphigoid.
    Ozog DM; Gogstetter DS; Scott G; Gaspari AA
    Arch Dermatol; 2000 Sep; 136(9):1133-8. PubMed ID: 10987869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucocutaneous Hyperpigmentation in a Patient With a History of Both Minocycline and Silver Ingestion.
    Fernandez-Flores A; Nguyen T; Cassarino DS
    Am J Dermatopathol; 2017 Dec; 39(12):916-919. PubMed ID: 28475520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment of Minocycline-Induced Facial Hyperpigmentation with a Combination of Chemical Peels and Intense Pulsed Light.
    Li Y; Zhen X; Yao X; Lu J
    Clin Cosmet Investig Dermatol; 2023; 16():253-256. PubMed ID: 36726812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Picosecond alexandrite laser is superior to Q-switched Nd:YAG laser in treatment of minocycline-induced hyperpigmentation: A case study and review of the literature.
    Barrett T; de Zwaan S
    J Cosmet Laser Ther; 2018; 20(7-8):387-390. PubMed ID: 29400580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Minocycline-induced hyperpigmentation: not uncommon, but nonetheless important to recognise].
    Voets PJ; Blommaert D; Keijsers RR; Alkemade HA
    Ned Tijdschr Geneeskd; 2016; 160():D483. PubMed ID: 27879178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minocycline-induced hyperpigmentation: comparison of 3 Q-switched lasers to reverse its effects.
    Nisar MS; Iyer K; Brodell RT; Lloyd JR; Shin TM; Ahmad A
    Clin Cosmet Investig Dermatol; 2013; 6():159-62. PubMed ID: 23754872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out of the Blue: A Case of Blue Subungual Discoloration Associated with Prolonged Tetracycline Use.
    Ahmad Y; Boutros H; Hanna K
    Cureus; 2020 Apr; 12(4):e7810. PubMed ID: 32467786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minocycline-induced hyperpigmentation.
    Hung PH; Caldwell JB; James WD
    J Fam Pract; 1995 Aug; 41(2):183-5. PubMed ID: 7636458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lingual hyperpigmentation associated with minocycline therapy.
    Meyerson MA; Cohen PR; Hymes SR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Feb; 79(2):180-4. PubMed ID: 7614181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new type of minocycline-induced cutaneous hyperpigmentation.
    Mouton RW; Jordaan HF; Schneider JW
    Clin Exp Dermatol; 2004 Jan; 29(1):8-14. PubMed ID: 14723711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline-induced hyperpigmentation involving the oral mucosa after short-term minocycline use.
    Filitis DC; Graber EM
    Cutis; 2013 Jul; 92(1):46-8. PubMed ID: 23961526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline-induced hyperpigmentation of tympanic membrane, sclera, teeth, and pinna.
    Reese S; Grundfast K
    Laryngoscope; 2015 Nov; 125(11):2601-3. PubMed ID: 26059453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline hydrochloride hyperpigmentation complicating treatment of pyoderma gangrenosum.
    Miralles ES; Nuñez M; Pérez B; Ledo A
    J Dermatol; 1994 Dec; 21(12):965-7. PubMed ID: 7868770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral presentation of minocycline-induced black bone disease.
    Odell EW; Hodgson RP; Haskell R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Apr; 79(4):459-61. PubMed ID: 7614206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline-induced cutaneous hyperpigmentation: confocal laser scanning microscope analysis.
    Dodiuk-Gad RP; de Morentin HM; Schafer J; Harel A; Neudorfer M; Misonzhnik F; Gitstein G; Rozenman D; Tur E; Brenner S
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):435-9. PubMed ID: 16643143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline decreases Th2 chemokines from M2 macrophages: Possible mechanisms for the suppression of bullous pemphigoid by traditional bullous disease drugs.
    Tanita K; Fujimura T; Sato Y; Lyu C; Aiba S
    Exp Dermatol; 2018 Nov; 27(11):1268-1272. PubMed ID: 30192415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Black bone disease of the foot: a case study and review of literature demonstrating a correlation of long-term minocycline therapy and bone hyperpigmentation.
    Kerbleski GJ; Hampton TT; Cornejo A
    J Foot Ankle Surg; 2013; 52(2):239-41. PubMed ID: 23312403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline-Induced Hyperpigmentation in a Patient Treated with Erlotinib for Non-Small Cell Lung Adenocarcinoma.
    Bell AT; Roman JW; Gratrix ML; Brzezniak CE
    Case Rep Oncol; 2017; 10(1):156-160. PubMed ID: 28413391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline-induced skin pigmentation: an update.
    Geria AN; Tajirian AL; Kihiczak G; Schwartz RA
    Acta Dermatovenerol Croat; 2009; 17(2):123-6. PubMed ID: 19595269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.